11304 Federal Register / Vol. 66, No. 37 / Friday, February 23, 2001 / Notices

Date: March 19, 2001.

Time: 8 a.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: Bethesda Marriott, 5151 Pooks Hill

Road, Bethesda, MD 20814.

Contact Person: Jeffrey M. Chernak, PhD,

The Bethesda Gateway Building, 7201

Wisconsin Avenue/Suite 2C212, Bethesda,

MD 20892, (301) 496–9666.

Name of Committee: National Institute on

Aging Initial Review Group. Neuroscience of

Aging Review Committee.

Date: March 21–22, 2001.

Time: 7:00 p.m. to 4:00 p.m.

Agenda: To review and evaluate grant

applications.

Place: Holiday Inn—Georgetown, 2101

Wisconsin Avenue, NW., Washington, DC

20007.

Contact Person: Louise L. Hsu, PhD, The

Bethesda Gateway Building, 7201 Wisconsin

Avenue/Suite 2C212, Bethesda, MD 20892,

(301) 496–9666.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.866, Aging Research,

National Institutes of Health, HHS)

Dated: February 13, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–4461 Filed 2–22–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Mental Health;

Notice of Closed Meetings

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meetings.

The meetings will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute of

Mental Health Special Emphasis Panel.

Date: March 14, 2001.

Time: 8:30 a.m. to 5:30 p.m.

Agenda: To review and evaluate grant

applications.

Place: Woodfin Suites Hotel, Conference

Room, 1380 Piccard Drive, Rockville, MD

20850.

Contact Person: Richard E. Weise, PhD,

Scientific Review Administrator, National

Institute of Mental Health, NIH, 6001

Executive Boulevard, Room 6206, MSC 9619,

Bethesda, MD 20892–9619, 301–443–7281.

Name of Committee: National Institute of

Mental Health Special Emphasis Panel.

Date: March 19, 2001.

Time: 8:30 a.m. to 5:30 p.m.

Agenda: To review and evaluate grant

applications.

Place: Holiday Inn Bethesda, 8120

Wisconsin Ave, Bethesda, MD 20814.

Contact Person: Richard E. Weise, PhD,

Scientific Review Administrator, National

Institute of Mental Health, NIH, 6001

Executive Boulevard, Room 6206, MSC 9619,

Bethesda, MD 20892–9619, 301–443–7281.

Name of Committee: National Institutue of

Mental Health Special Emphasis Panel.

Date: March 20, 2001.

Time: 11:00 a.m. to 1:00 p.m.

Agenda: To review and evaluate grant

applications.

Place: Neuroscience Center, National

Institutes of Health, 6001 Executive Blvd.,

Bethesda, MD 20892 (Telephone Conference

Call).

Contact Person: Michael J. Kozak, PhD,

Scientific Review Administrator, Division of

Extramural Activities, National Institute of

Mental Health, NIH, Neuroscience Center,

6001 Executive Blvd., Room 6138, MSC 9606,

Bethesda, MD 20892–9606 301–443–1340.

Name of Committee: National Institute of

Mental Health Special Emphasis Panel.

Date: March 21, 2001.

Time: 8 am to 5 pm.

Agenda: To review and evaluate grant

applications.

Place: Holiday Inn Bethesda, 8210

Wisconsin Ave, Bethesda, MD 20814.

Contact Person: Houmam H Araj, PhD,

Scientific Review Administrator, Division of

Extramural Activities, National Institute of

Mental Health, NIH, Neuroscience Center,

6001 Executive Blvd., Room 6150, MSC 9608,

Bethesda, Md 20892–9608, 301–443–1340.

Name of Committee: National Institute of

Mental Health Special Emphasis Panel.

Date: March 29, 2001.

Time: 11 a.m. to 1:30 p.m

Agenda: To review an evaluate grant

applications.

Place: Neuroscience Center, National

Institutes of Health, 6001 Executive Blvd.,

Bethesda, MD 20892 (Telephone Conference

Call).

Contact Person: Michael J. Kozak, PhD,

Scientific Review Administrator, Division of

Extramural Activities, National Institute of

Mental Health, NIH, Neuroscience Center,

6001 Executive Blvd., Room 6138, MSC 9606,

Bethesda, Md 20892–9606, 301–443–1340.

Name of Committee: National Institute of

Mental Health Special Emphasis Panel.

Date: April 6, 2001.

Time: 9 a.m. to 1 p.m.

Agenda: To review and evaluate grant

applications.

Place: Holiday Inn Bethesda, 8120

Wisconsin Avenue, Bethesda, MD 20814.

Contact Person: Richard E. Weise, PhD,

Scientific Review Administrator, National

Institute of Mental Health, NIH, 6001

Executive Boulevard, Room 6206, MSC 9619,

Bethesda, MD 20892–9619, 301–443–7281.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.242, Mental Health Research

Grants; 93.281, Scientist Development

Award, Scientist Development Award for

Clinicians, and Research Scientist Award;

93.282, Mental Health National Research

Service Awards for Research Training,

National Institutes of Health, HHS)

Dated: February 13, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–4463 Filed 2–22–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Library of Medicine; Notice of

Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Library of

Medicine Special Emphasis Panel Telephone

Conference, ‘‘A History of Medicine—

Volume–IV Medieval Medicine.’’

Date: February 21, 2001.

Time: 2:00 p.m. to 3:00 p.m.

Agenda: To review and evaluate grant

applications.

Place: National Library of Medicine,

Division of Extramural Programs, 6705

Rockledge Drive, Suite 301, Bethesda, MD

20892 (Telephone Conference Call).

Contact Person: Milton Corn, MD,

Associate Director, Office of Extramural

Programs, National Library of Medicine,

National Institutes of Health, One Rockledge

Centre, Suite 301, 6705 Rockledge Drive,

MSC 6075, Bethesda, MD 20892–6075, (301)

496–4621.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.879, Medical Library

Assistance, National Institutes of Health,

HHS)

Federal Register / Vol. 66, No. 37 / Friday, February 23, 2001 / Notices 11305

Dated: February 13, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–4459 Filed 2–22–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Library of Medicine; Notice of

Meeting

Pursuant to section 10(a) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of a meeting of the

PubMed Central National Advisory

Committee.

The meeting will be open to the

public, with attendance limited to space

available. Individuals who plan to

attend and need special assistance, such

as sign language interpretation or other

reasonable accommodations, should

notify the Contact Person listed below

in advance of the meeting.

Name of Committee: PubMed Central

National Advisory Committee.

Date: March 21, 2001.

Time: 8:30 a.m. to 4 p.m.

Agenda: Review of Redesignated PMC

System.

Place: National Library of Medicine, Board

Room, Bldg. 38, 2E–09, 8600 Rockville Pike,

Bethesda, MD 20894.

Contact Person: David J. Lipman, MD,

Director, Natl. Ctr. for Biotechnology

Information, National Library of Medicine,

Department of Health and Human Services,

Bethesda, MD 20894.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.879, Medical Library

Assistance, National Institutes of Health,

HHS)

Dated: February 13, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–4460 Filed 2–22–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

Meeting of the Recombinant DNA

Advisory Committee

Pursuant to section 10(a) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of a meeting of the

Recombinant DNA Advisory Committee

(RAC) and a Safety Symposium on Gene

Transfer Research.

The Safety Symposium on Gene

Transfer Research will be held from 8

a.m. to 6 p.m. on March 7, 2001 at the

Doubletree Hotel, 1750 Rockville Pike,

Rockville, MD 20852. The symposium

will explore safety considerations in the

Use of Adeno-Associated Virus Vectors

in Gene Transfer Clinical Trials.

The RAC meeting will be held from

8:30 a.m. to 5:30 p.m. on March 8, 2001

at the National Institutes of Health

(NIH), Building 31, C Wing, Conference

Room 10, 9000 Rockville Pike,

Bethesda, MD 20892. The Committee

will review selected human gene

transfer protocols; a proposed action to

amend the NIH Guidelines with regard

to NIH policy on serious adverse event

reporting; data management activities

related to human gene transfer clinical

trials; and other matters to be

considered by the Committee.

Both meetings are open to the public

with attendance limited to space

available. Draft meeting agendas and

other information will be posted at the

Office of Biotechnology Activities’

website: http://www4.od.nih.gov/oba

Individuals who wish to provide

public comments or who plan to attend

the meeting and need special assistance,

such as sign language interpretation or

other reasonable accommodations,

should notify Kelly Fennington,

Program Analyst, Office of

Biotechnology Activities by telephone at

301 496–9838 or E-mail at

FenningK@od.nih.gov

Dated: February 13, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–4455 Filed 2–22–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

Center for Scientific Review; Notice of

Closed Meetings

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meetings.

The meetings will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: February 28, 2001.

Time: 2:00 p.m. to 4:00 p.m.

Agenda: To review and evaluate grant

applications.

Place: NIH, Rockledge 2, Bethesda, MD

20892 (Telephone Conference Call).

Contact Person: Victor A. Fung, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institute of

Health, 6701 Rockledge Drive, Room 4120,

MSC 7804, Bethesda, MD 20892, 301–435–

3504, fungv@csr.nih.gov.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: March 2, 2001.

Time: 12:00 p.m. to 2:30 p.m.

Agenda: To review and evaluate grant

applications.

Place: NIH, Rockledge 2, Bethesda, MD

20892 (Telephone Conference Call).

Contact Person: John Bishop, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 5180,

MSC 7844, Bethesda, MD 20892, (301) 435–

1250.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: March 6, 2001.

Time: 1:00 p.m. to 2:30 p.m.

Agenda: To review and evaluate grant

applications.

Place: NIH, Rockledge 2, Bethesda, MD

20892 (Telephone Conference Call).

Contact Person: Syed Quadri, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 4144,

MSC 7804, Bethesda, MD 20892, (301) 435–

1211.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: March 6, 2001.

Time: 12:00 p.m. to 1:30 p.m.

Agenda: To review and evaluate grant

applications.

Place: NIH, Rockledge 2, Bethesda, MD

20892 (Telephone Conference Call).

Contact Person: Daniel R. Kenshalo, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 5176,

MSC 7844, Bethesda, MD 20892, 301–435–

1255.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: March 8–9, 2001.

Time: 8:00 a.m. to 5:00 p.m.

Agenda: To review and evaluate grant

applications.

Place: Holiday Inn, 8120 Wisconsin

Avenue, Bethesda, MD 20814.